KI-Unterstützung für unternehmerische ethische Dilemmata

Heim

KI-Prompt-Liste

Philosophie/Religion

Ethische Entscheidungsunterstützung

${:__('collect %s',Ethische Entscheidungsunterstützung)}$

Philosophie/Religion

Analysieren Sie moralische Konflikte in Geschäftsszenarien unter Verwendung utilitaristischer und deontologischer Rahmenwerke, um konforme und ethische Entscheidungsempfehlungen zu geben.

Prompt-Inhalt

Kopieren

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.

Kopieren

Treten Sie als Unternehmensethikberater auf und führen Sie eine tiefgehende moralische Analyse des folgenden konkreten Geschäftsszenarios durch: Ein Pharmaunternehmen stellt fest, dass sein hochprofitables, bereits vermarktetes Medikament leichte, aber langfristige Nebenwirkungen hat. Ein Rückruf würde enorme finanzielle Verluste verursachen und die Interessen der Aktionäre beeinträchtigen, während ein Unterlassen des Rückrufs die Gesundheit einiger Patienten schädigen könnte. Bitte bewerten Sie die ethischen Gewichte beider Optionen – Rückruf und Nicht-Rückruf – unter Kombination zweier philosophischer Rahmenwerke: Utilitarismus (größtes Glück für die größte Zahl) und Deontologie (die moralische Natur der Handlung selbst, wie Ehrlichkeit und Nicht-Schaden). Vermeiden Sie einfache binäre Urteile; leiten Sie stattdessen den besten Handlungsweg ab, der moralisch vertretbar ist und mit langfristiger Corporate Social Responsibility (CSR) übereinstimmt, indem Sie die Interessen verschiedener Interessengruppen (Patienten, Aktionäre, Mitarbeiter, Gesellschaft) abwägen und die Begründung erläutern.

Kopieren

Teilen Klicken Sie, um den Link zu kopieren

Kommentare (0)

0/300

Einreichen

Empfehlung

Ethische Entscheidungsunterstützung

Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.

Ethische Entscheidungsunterstützung

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.

Ethische Entscheidungsunterstützung

Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.

Ethische Entscheidungsunterstützung

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.

Ethische Entscheidungsunterstützung

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.

Ethische Entscheidungsunterstützung

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving new drug faces a situation where clinical trial data is partially missing, yet market demand is urgent. Please analyze the ethical consequences of continuing or pausing the trial by combining utilitarian considerations for the greatest good of the majority with deontological requirements for procedural justice, and provide specific action recommendations that balance legal compliance, social trust, and long-term business sustainability, ensuring the decision-making process is transparent and adheres to the highest industry ethical standards.